Shanghai Medicilon Inc (688202) — Capital Reinvestment Ratio
Shanghai Medicilon Inc (688202) has a Capital Reinvestment Ratio of 3.63x as of June 2022, meaning it reinvests 4% of its operating cash flow (CN¥9.55 Million) in capital expenditures (CN¥34.63 Million). Check Shanghai Medicilon Inc tangible book value ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Shanghai Medicilon Inc Capital Reinvestment Ratio (2016–2025)
This chart tracks Shanghai Medicilon Inc's Capital Reinvestment Ratio across 8 annual periods. For the full cash flow conversion analysis, see 688202 cash flow metrics.
Annual Capital Reinvestment Ratio for Shanghai Medicilon Inc (2016–2025)
Year-by-year Capital Reinvestment Ratio for Shanghai Medicilon Inc from 2016 to 2025. See Shanghai Medicilon Inc free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.66x | CN¥105.17 Million | CN¥69.03 Million | ▼ -92.7% |
| 2023 | 9.01x | CN¥33.32 Million | CN¥300.10 Million | ▲ +1293.7% |
| 2021 | 0.65x | CN¥452.94 Million | CN¥292.71 Million | ▲ +13.1% |
| 2020 | 0.57x | CN¥207.77 Million | CN¥118.72 Million | ▼ -65.8% |
| 2019 | 1.67x | CN¥58.30 Million | CN¥97.38 Million | ▲ +84.5% |
| 2018 | 0.91x | CN¥71.11 Million | CN¥64.37 Million | ▲ +14.8% |
| 2017 | 0.79x | CN¥74.70 Million | CN¥58.91 Million | ▼ -31.5% |
| 2016 | 1.15x | CN¥34.13 Million | CN¥39.31 Million | — |